Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 3

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other neoplasm 3Gynecologic 2

Conditions

Uterine Cervical Neoplasms 5Uterine Cervical Dysplasia 3Precancerous Conditions 3Papillomavirus Infections 3Atypical Squamous Cells of the Cervix 1

Interventions

Biopsy 8Polymerase Chain Reaction 6Peripheral Blood Stem Cell Transplantation 5Epoetin Alfa 5Sulindac 4Microarray Analysis 4Gene Expression Profiling 4Cyclophosphamide 4Colposcopy 4Cetuximab 4Celecoxib 4fludarabine phosphate 3Vaginal Smears 3Selenium 3Methotrexate 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Eflornithine 3Darbepoetin alfa 3Aspirin 3Antilymphocyte Serum 3Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Methylprednisolone 2Light Coagulation 2Interferon-alpha 2In Situ Hybridization, Fluorescence 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Precancerous Conditions × Vaginal Smears × Clear all
NCT00003384 2015-05-29

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

GOG Foundation

Phase NA Completed
684 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Precancerous Conditions

NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00977392 2013-08-07

Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

National Cancer Institute (NCI)

Completed
3,000 enrolled
Other neoplasm

Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡